VC/I  Lagunita Biosciences

https://www.lagunitabio.com/





     Office Locations:

1490 O’Brien Dr Suite C
Menlo Park, CA 94025
Phone: 650-539-0715

 

Stages:

  • Early
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Lagunita Biosciences is a healthcare investment company and incubator that creates and grows early stage companies to commercialize impactful translational science that addresses significant clinical needs. The firm evaluates opportunities in five key areas that correspond to the strengths and expertise of its team and network: Ophthalmology, Protein engineering and drug discovery, Surgical devices, Optical diagnostics and therapeutics, and Mobile health.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Darius Kharabi Chief Operating Officer
    Jennifer Cochran Chief Scientist
    Mark S. Blumenkranz Chairman, Founding Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      08/06/2018


      Kedalion Therapeutics


      CA


      $5,000,000


      Series A


      07/31/2018


      Verana Health


      CA


      $30,000,000


      Series C


     

    Portfolio companies include:

     

    Recent News: